Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Adam, DeZure"'
Autor:
Rita Humeniuk, Kavita Juneja, Shuguang Chen, Scott Ellis, Olena Anoshchenko, Deqing Xiao, Aaron Share, Matthew Johnston, Santosh Davies, Adam DeZure, Joe Llewellyn, Anu Osinusi, Helen Winter, Sandhya Girish, Ramesh Palaparthy, Mark Dresser
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 11, Pp 2276-2288 (2023)
Abstract Intravenous remdesivir (RDV) is US Food and Drug Administration–approved for hospitalized and nonhospitalized individuals with coronavirus disease 2019. RDV undergoes intracellular metabolic activation to form the active triphosphate, GS
Externí odkaz:
https://doaj.org/article/ab437c86ec334aa9a0a440c7bdc247ab
Autor:
Samit Desai, Kristen M. Marks, Suzanne J Rose, Sigal Yawetz, Pritha Sen, Shawn Mazur, Jose F. Suarez, Diana M. Brainard, Yang Zhao, Matthew D Sims, Moupali Das, Magdalena E. Sobieszczyk, Cecilia Big, Ilona T. Goldfarb, Brian G. Blackburn, Ai-ris Y. Collier, Christoph C Carter, Susanna K Tan, Olga A. Kovalenko, Geeta K. Swamy, William R. Short, Jason Hindman, Adam DeZure, Tom Hahambis, Richard M. Burwick, Gregory Morlin, Adi Hirshberg, Anu Osinusi, Rebecca Zash, Laura Telep, Tilly A. Varughese, Anand P Chokkalingam, Mariam Naqvi, E Milunka Kojic, Kathryn E. Stephenson, Jeanne S. Sheffield, Oriol Manuel
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
Clinical infectious diseases, vol. 73, no. 11, pp. e3996-e4004
Clinical Infectious Diseases
Clinical infectious diseases, vol. 73, no. 11, pp. e3996-e4004
Background Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in adults, but data in pregnant women are limited. We describe outcomes in the first 86 pregnant women with severe COVID-19 who were treated with remdesivir. Methods
Autor:
Anu Osinusi, Neal Marshall, Andres Camacho-Gonzalez, Anand P. Chokkalingam, Stefan H.F. Hagmann, Christoph C Carter, Polly Desai, Sarjita Naik, Moupali Das, Yang Zhao, Philip Lee, Paolo Bonfanti, Huyen Cao, Ana Méndez-Echevarría, Giuseppe Lapadula, Ioannis Katsarolis, Laura Telep, Adam DeZure, Diana M. Brainard, David L. Goldman, Cheryl A. Pikora, Alasdair Bamford, Margaret L. Aldrich
Publikováno v:
Pediatrics
OBJECTIVES: Remdesivir shortens time to recovery in adults with severe coronavirus disease 2019 (COVID-19), but its efficacy and safety in children are unknown. We describe outcomes in children with severe COVID-19 treated with remdesivir. METHODS: S
Autor:
Jennifer Cunningham, Marta Mora-Rillo, Robert P. Myers, Gary M. Green, Polly Desai, Toshitaka Maeno, Antonella D’Arminio Monforte, Yoshikazu Mutoh, Emanuele Nicastri, Ilana Henne, Susanna K. Tan, Erika Asperges, Jonathan Grein, Saad Ismail, Alex Studemeister, Rentaro Oda, Anuj Gaggar, Anu Osinusi, Kikuo Yo, Erwan L’Her, Huyen Cao, Hideaki Kato, Duc Nguyen, Seema Ahmed, Daniel Shin, Marco Massari, John Redinski, Giuseppe Lapadula, Lijie Zhong, Shingo Chihara, Laura Telep, Alexander Zoufaly, Daniel Chelliah, Ewa Verweij, Timothy Flanigan, Lucinda Winterbourne, Robertino Mera, Eugenia Quiros-Roldan, Diana M. Brainard, Adam DeZure, Leighann Timbs, Norio Ohmagari, Stuart H. Cohen, Sumit Majumder, Richard Childs, François-Xavier Lescure, Jorge Bernett, Emon Elboudwarej, Yang Zhao, Anand Chokkalingam, Scott Sellers, George Diaz, Torsten Feldt, Margaret L. Green, Danny Chen, Antonella Castagna
Publikováno v:
New England Journal of Medicine
The New England Journal of Medicine
The New England journal of medicine, vol 382, iss 24
The New England Journal of Medicine
The New England journal of medicine, vol 382, iss 24
Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a compassionate-use basis to patients hospitalized with Covid-19, the illness
Autor:
Pamela Costner, Richard E. Stafford, Ingelise J. Gordon, Lindsay S. Garver, Adam DeZure, B. Kim Lee Sim, Christopher V. Plowe, LaSonji A. Holman, Peter F. Billingsley, Barney S. Graham, Stephen L. Hoffman, Floreliz Mendoza, Kathryn L Zephir, Laura Novik, Abraham G. Eappen, Mario Roederer, Martha Nason, Minglin Li, Mary E. Enama, Andrew S. Ishizuka, Robert A. Seder, Julie E. Ledgerwood, Anita Manoj, Nina M. Berkowitz, Jamie G. Saunders, Anusha Gunasekera, Adam Ruben, Barbara J. Flynn, Thomas L. Richie, Matthew B. Laurens, Cynthia S. Hendel, Sarah H. Plummer, Tooba Murshedkar, Andrea A. Berry, Natasha Kc, Tao Li, Kirsten E. Lyke, Sumana Chakravarty, Eric R. James
Publikováno v:
Proceedings of the National Academy of Sciences. 114:2711-2716
A live-attenuated malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to
Autor:
Michelle Makiya, Sergio D. Rosenzweig, Maureen J. O'Sullivan, Chi Ma, Adam DeZure, Jennifer Stoddard, Joshua D. Milner, Alexandra F. Freeman, Julie E. Niemela, Amy D. Klion, Stefania Pittaluga, Sophie Hambleton, Brian Cauff, Mark Raffeld, Grainne M. O'Regan, Liqiang Xi, T. Ronan Leahy, Gary Kleiner
Publikováno v:
Blood. 129:650-653
To the editor: Somatic, gain-of-function mutations in STAT3 and STAT5 have been described in leukemias and lymphomas[1][1][⇓][2][⇓][3][⇓][4][⇓][5]-[6][6] and, more recently, in CD3-CD4+ T cells from a patient with lymphocytic variant hypereos
Autor:
Mary E. Enama, Sarah F. Andrews, Julie E. Ledgerwood, Richard A. Koup, Richard M. Schwartz, Adam DeZure, Sarah H. Plummer, Galina Yamshchikov, Ingelise J. Gordon, Emily E. Coates, Michelle C. Crank, John R. Mascola, Terrence M. Tumpey, Xiangjie Sun, Barney S. Graham, Kathryn L Zephir, Adrian B. McDermott, Zonghui Hu, Florence Kaltovich, Robert T. Bailer
Publikováno v:
npj Vaccines, Vol 2, Iss 1, Pp 1-6 (2017)
NPJ Vaccines
npj Vaccines
NPJ Vaccines
npj Vaccines
A novel avian influenza subtype, A/H7N9, emerged in 2013 and represents a public health threat with pandemic potential. We have previously shown that DNA vaccine priming increases the magnitude and quality of antibody responses to H5N1 monovalent ina
Autor:
Andrew S, Ishizuka, Kirsten E, Lyke, Adam, DeZure, Andrea A, Berry, Thomas L, Richie, Floreliz H, Mendoza, Mary E, Enama, Ingelise J, Gordon, Lee-Jah, Chang, Uzma N, Sarwar, Kathryn L, Zephir, LaSonji A, Holman, Eric R, James, Peter F, Billingsley, Anusha, Gunasekera, Sumana, Chakravarty, Anita, Manoj, MingLin, Li, Adam J, Ruben, Tao, Li, Abraham G, Eappen, Richard E, Stafford, Natasha, K C, Tooba, Murshedkar, Hope, DeCederfelt, Sarah H, Plummer, Cynthia S, Hendel, Laura, Novik, Pamela J M, Costner, Jamie G, Saunders, Matthew B, Laurens, Christopher V, Plowe, Barbara, Flynn, William R, Whalen, J P, Todd, Jay, Noor, Srinivas, Rao, Kailan, Sierra-Davidson, Geoffrey M, Lynn, Judith E, Epstein, Margaret A, Kemp, Gary A, Fahle, Sebastian A, Mikolajczak, Matthew, Fishbaugher, Brandon K, Sack, Stefan H I, Kappe, Silas A, Davidson, Lindsey S, Garver, Niklas K, Björkström, Martha C, Nason, Barney S, Graham, Mario, Roederer, B Kim Lee, Sim, Stephen L, Hoffman, Julie E, Ledgerwood, Robert A, Seder
Publikováno v:
Nature medicine. 22(6)
Autor:
Sumana Chakravarty, Eric R. James, Tao Li, Kirsten E. Lyke, Abraham G. Eappen, Mario Roederer, Laura Novik, Adam Ruben, Uzma N. Sarwar, Anita Manoj, Sebastian A. Mikolajczak, Hope Decederfelt, Cynthia S. Hendel, Brandon K. Sack, Stefan H. I. Kappe, Pamela Costner, Matthew B. Laurens, Mary E. Enama, Adam DeZure, Niklas K. Björkström, Jay Noor, Lindsey S. Garver, Silas A. Davidson, Natasha K C, B. Kim Lee Sim, William R Whalen, Julie E. Ledgerwood, Stephen L. Hoffman, Barbara J. Flynn, Minglin Li, Andrew S. Ishizuka, Robert A. Seder, Martha Nason, Judith E. Epstein, Peter F. Billingsley, Lee-Jah Chang, Sarah H. Plummer, Ingelise J. Gordon, Christopher V. Plowe, Kailan Sierra-Davidson, Richard E. Stafford, Margaret A. Kemp, Barney S. Graham, Anusha Gunasekera, Kathryn L Zephir, Srinivas S. Rao, Thomas L. Richie, Tooba Murshedkar, LaSonji A. Holman, John Paul Todd, Floreliz Mendoza, Matthew Fishbaugher, Jamie G. Saunders, Andrea A. Berry, Gary A. Fahle, Geoffrey M. Lynn
Publikováno v:
Nature medicine. 22(6)
An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown. We assessed how vaccine
Autor:
Adam DeZure, Barney S. Graham
Infectious diseases continue to plague mankind and evolve to keep pace with the efforts to control them. Sir William Osler captured the ongoing fear of infectious pathogens when he said, “Humanity has but three great enemies: fever, famine, and war
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::142c0a1d960fa36faadab324cb97b33f
https://doi.org/10.1016/b978-0-12-802174-3.00028-x
https://doi.org/10.1016/b978-0-12-802174-3.00028-x